We are live on ! Find out more
WA

Wilshire Advisors Portfolio holdings

AUM $9.96M
1-Year Est. Return 76.57%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+76.57%
3 Year Est. Return
+100.3%
5 Year Est. Return
+82.67%
10 Year Est. Return
+137%
AUM
$193M
AUM Growth
+$13M
Cap. Flow
-$2.44M
Cap. Flow %
-1.26%
Top 10 Hldgs %
99.99%
Holding
11
New
1
Increased
3
Reduced
5
Closed
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
1
iShares Core S&P 500 ETF
IVV
$876B
$70.2M 36.36%
146,965
-4,091
-3% -$1.83M
IEFA icon
2
iShares Core MSCI EAFE ETF
IEFA
$186B
$44.1M 22.82%
626,311
-10,949
-2% -$722K
AGG icon
3
iShares Core US Aggregate Bond ETF
AGG
$138B
$33.1M 17.15%
333,641
+3,487
+1% +$332K
STIP icon
4
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
$19.6M 10.17%
199,203
-4,430
-2% -$432K
REET icon
5
iShares Global REIT ETF
REET
$5.12B
$11.8M 6.1%
487,030
+17,576
+4% +$384K
IEMG icon
6
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$9.64M 4.99%
190,624
+1,820
+1% +$88.2K
IJR icon
7
iShares Core S&P Small-Cap ETF
IJR
$109B
$2.18M 1.13%
20,182
-1,679
-8% -$162K
IGSB icon
8
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$2.12M 1.1%
41,344
-2,118
-5% -$106K
ALLK
9
DELISTED
Allakos
ALLK
$205K 0.11%
75,055
LDI icon
10
loanDepot
LDI
$548M
$97.6K 0.05%
27,727
FATE icon
11
Fate Therapeutics
FATE
$281M
$15.3K 0.01%
+4,083
New +$9.64K

Similar funds

Wilshire Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Wilshire Advisors held 11 positions worth $193M, up 7.2% from $180M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Wilshire Advisors's Q4 2023 filing shows 1 new, 3 increased and 5 reduced positions. Its largest new stake was Fate Therapeutics: 4,083 shares worth $15.3K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.83M.

By sector, the portfolio is most concentrated in Healthcare at 0.11% of assets, up from 0.09% a quarter earlier, followed by Financials.

  • Wilshire Advisors's largest Q4 2023 buy was Fate Therapeutics: 4,083 shares worth $15.3K.
  • Wilshire Advisors added most to iShares Global REIT ETF in Q4 2023, an estimated $384K increase.
  • Wilshire Advisors's biggest Q4 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.83M.
  • Wilshire Advisors's ten largest holdings make up 100% of its $193M portfolio in Q4 2023.
  • Wilshire Advisors opened 1 new position and closed 0 in Q4 2023.
  • Wilshire Advisors's portfolio value rose 7.2% quarter-over-quarter to $193M.

Based on Wilshire Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.